Infrasound and AI based Auscultation Products for Cardiopulmonary Diseases

Completion of development and full commercialization of full spectrum auscultation products including infrasound and artificial intelligence for the diagnosis, monitoring and screening for prevalent cardiopulmonary diseases. The market for home monitoring of CHF, COPD and asthma using the PyXy is $500B worldwide. The market for the VoqX smart stethoscope for clinicians is $18B worldwide. Project funds will be used to set up high capacity manufacturing for the VoqX, complete development of the PyXy and develop and clear artificial intelligence applicatons for cardiopulmonary disease classification.